This column is the second of a 3-part series describing cases where general medical knowledge, including psychiatric and clinical pharmacology, were instrumental in determining dereliction and direct cause in a
Lower starting doses and slower dose escalations than those used in clinical trials are recommended because of the suggestion that the risk of rash may be decreased by lower starting doses and slower dose escalations. Therefore, maintenance doses will take longer to reach in clinical practice than...
Lower starting doses and slower dose escalations than those used in clinical trials are recommended because of the suggestion that the risk of rash may be decreased by lower starting doses and slower dose escalations. Therefore, maintenance doses will take longer to reach in clinical practice than...
2.1.1. The Relationship of LTG and the Blood-Brain Barrier (BBB) LTG has been shown to have potential therapeutic uses in various CNS diseases, including bipolar disorder, epilepsy, neuropathic pain, and others. We know that the exact mechanism of action of LTG is not fully understood. One...